An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study

被引:106
作者
Borggreve, Susanna E.
Hillege, Hans L.
Wolffenbuttel, Bruce H. R.
de Jong, Paul E.
Zuurman, Mike W.
van der Steege, Gerrit
van Tol, Arie
Dullaart, Robin P. F.
机构
[1] Univ Groningen, Med Ctr, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Dept Nephrol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen, Dept Genotyping Facil, NL-9700 RB Groningen, Netherlands
[5] Univ Groningen, Dept Med Biol, NL-9700 RB Groningen, Netherlands
[6] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands
关键词
D O I
10.1210/jc.2005-2322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several cholesteryl ester transfer protein (CETP) polymorphisms affect high-density lipoprotein (HDL) cholesterol, but the impact of CETP gene variants on incident coronary disease in the general population is uncertain after correction for their effect on HDL cholesterol. Design: We determined relationships between the CETP - 629C -> A promoter (n = 8141), the TaqIB (n = 8289), and the I405V (n = 8265) polymorphisms, serum lipids, C-reactive protein, and clinical factors with incident coronary heart disease (defined as death from or hospitalization for myocardial infarction, ischemic heart disease, or coronary intervention) during a median of 4.94 yr follow-up. Subjects: A predominantly Caucasian general population was studied. Results: HDL cholesterol was 0.08 mmol/liter higher in -629A carriers than in -629CC homozygotes (P < 0.001). The unadjusted coronary hazard was 1.26 [ 95% confidence interval (CI), 0.95 - 1.68; P = 0.11] in A carriers compared with CC homozygotes and increased to 1.46 (95% CI, 1.10 - 1.95; P = 0.01) after adjustment for HDL cholesterol. This effect remained after additional adjustment for apolipoprotein A-I, triglycerides, C-reactive protein, age, and gender. Likewise, the HDL-cholesterol-adjusted hazard ratio was also higher in AA than in CC homozygotes (hazard ratio, 1.72; 95% CI, 1.22 - 2.42; P < 0.01). Similar findings were obtained with the TaqIB polymorphism. The 405V allele was weakly associated with incident coronary heart disease after HDL cholesterol adjustment (P = 0.09). Conclusions: A common CETP promoter polymorphism, which beneficially contributes to higher HDL cholesterol, is paradoxically associated with increased incidence of coronary disease in the general population. Thus, CETP gene variation may affect coronary risk apart from the level of HDL cholesterol.
引用
收藏
页码:3382 / 3388
页数:7
相关论文
共 52 条
  • [1] Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
    Agerholm-Larsen, B
    Nordestgaard, BG
    Steffensen, R
    Jensen, G
    Tybjærg-Hansen, A
    [J]. CIRCULATION, 2000, 101 (16) : 1907 - 1912
  • [2] Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis
    Arca, M
    Montali, A
    Ombres, D
    Battiloro, E
    Campagna, F
    Ricci, G
    Verna, R
    [J]. CLINICAL GENETICS, 2001, 60 (05) : 374 - 380
  • [3] Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
    Barter, PJ
    Rye, KA
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) : 377 - 382
  • [4] Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease
    Blankenberg, S
    Rupprecht, HJ
    Bickel, C
    Jiang, XC
    Poirier, O
    Lackner, KJ
    Meyer, J
    Cambien, F
    Tiret, L
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) : 1983 - 1989
  • [5] Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment - Individual patient meta-analysis of 13,677 subjects
    Boekholdt, SM
    Sacks, FM
    Jukema, JW
    Shepherd, J
    Freeman, DJ
    McMahon, AD
    Cambien, F
    Nicaud, V
    de Grooth, GJ
    Talmud, PJ
    Humphries, SE
    Miller, GJ
    Eiriksdottir, G
    Gudnason, V
    Kauma, H
    Kakko, S
    Savolainen, MJ
    Arca, M
    Montali, A
    Liu, S
    Lanz, HJ
    Zwinderman, AH
    Kuivenhoven, JA
    Kastelein, JJP
    [J]. CIRCULATION, 2005, 111 (03) : 278 - 287
  • [6] Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
    Boekholdt, SM
    Kuivenhoven, JA
    Wareham, NJ
    Peters, RJG
    Jukema, JW
    Luben, R
    Bingham, SA
    Day, NE
    Kastelein, JJP
    Khaw, KT
    [J]. CIRCULATION, 2004, 110 (11) : 1418 - 1423
  • [7] CETP gene variation: relation to lipid parameters and cardiovascular risk
    Boekholdt, SM
    Kuivenhoven, JA
    Hovingh, GK
    Jukema, JW
    Kastelein, JJP
    van Tol, A
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (04) : 393 - 398
  • [8] Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
    Boekholdt, SM
    Thompson, JF
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (06) : 1080 - 1093
  • [9] The effect of cholesteryl ester transfer protein-629C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides
    Borggreve, SE
    Hillege, HL
    Wolffenbuttel, BHR
    de Jong, PE
    Bakker, SJL
    van der Steege, G
    van Tol, A
    Dullaart, RPF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) : 4198 - 4204
  • [10] Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins
    Borggreve, SE
    de Vries, R
    Dullaart, RPF
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) : 1051 - 1069